Astellas Pharma has received approval from the FDA for VYLOY in conjunction with chemotherapy, for the treatment of advanced ...

While adverse events (AEs) were reported for 97% of trial participants, such cases were predominantly mild to moderate.

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

The US FDA has approved AbbVie's VYALEV to treat motor fluctuations in adults with advanced Parkinson's disease (PD).

TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (bexagliflozin) to patients in sub-Saharan ...

An FDA AdCom in September recommended against full approval for Ocaliva by a 13-1 vote for the treatment of primary biliary ...

Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enhance the development of next-generation RLTs.

With less than three weeks until Americans cast their vote, what would healthcare look under a Harris or Trump administration ...

In the US, diagnosed prevalence is anticipated to increase across all opioid addiction patient segments. Credit: Iryna Imago ...

Lundbeck is to acquire Longboard for $2.6bn equity value in a move set to enhance its capabilities within neuro-rare ...

A potential three-year framework agreement between the Greek government and the pharmaceutical industry, starting at the ...

Inventiva will gain a new chairman following the deal as it presses ahead with a Phase III trial for its lead asset.